If side effects are intolerable, your provider can work with you to develop an appropriate management plan, which might include temporary dose reduction, extended time at a lower dose, or transition to an alternative medication if necessary
The typical research protocol involves subcutaneous injection of 5-10 mg daily for 10-20 consecutive days, repeated in 4-6 month cycles
Limitations There are several limitations inherent to the retrospective clinical observation including missing data and a lack of untreated individuals to act as a control arm
Your Health, Simplified
Australian POTS Foundation is the peak Australian patient organisation for POTS and related conditions and provides excellent resources for patients and families
Additionally, our medical team works closely with you to develop a customized plan that optimizes your health outcomes, whether you're seeking relief from chronic fatigue, skin rejuvenation, or enhanced overall wellness